TAVR in Bicuspid Patients: Are Outcomes the Same in Men and Women?

Bicuspid aortic valve stenosis (BAV) has not yet been analyzed in large, randomized studies, and TAVR in this scenario has been assessed only by small fairly studies. However, the information available is quite promising.  

TAVI en bicúspides

TAVR in women generally presents more complications than in men, but severe bicuspid aortic valve stenosis receiving TAVR has not been well looked at. 

This study included 510 patients from one singe center. 225 women (44.1%) and 285 men.

The valve most used was Venus-A Valve (Venus Medtech).

Mean age was 72; men presented more comorbidities, such as kidney failure, COPD and prior heart disease and PCI, in addition to lower left ventricular ejection fraction and more aortic failure associated to stenosis. 

On the other hand, women presented higher aortic velocity and less ascending aortic dilation. 

STS was similar: 5.6±3.8% for women and 4.9±4.2 for men (P=0.066).

Read also: Aspiration Thrombectomy in Acute Coronary Syndrome: Is the Japanese Perspective a Strategy to Emulate?

CT showed type 0 BAV was the most frequent in women and Type I in men. The latter presented more calcification, with larger aortic annuli, valve area and aortic root size. 

During the procedure, the need for a second valve was greater in men. However, there were more vascular complications in women.  

At hospital level, there were no differences in mortality or stroke, neither in need for pacemaker implantation (women 17.1% vs. 22.5% p=0.1).

Read also: Balloon expandable vs Self-Expanding Valves: The Best Option for ViV-TAVR in Small Annuli.

At 30 days and one year, there were no differences in mortality.

Eco-Doppler were analyzed at 30 days and one year. Women presented higher gradient but fewer major to mild paravalvular leaks without reaching statistical value. Both groups improved ejection fraction and presented reduced ventricular mass.

At multivariable analysis, bleeding was a mortality predictor in women while creatinine level and aortic root diameter >45 mm were predictors in men.

Conclusion

In patients with bicuspid aortic valves receiving TAVR, women presented fewer comorbidities, while men more often presented type I BAV, more calcification and larger aortic roots. At hospital level, men presented better evolution, fewer complications but more need of a second valve. Survival at one year was similar between sexes. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Sex Difference in Outcomes Following Transcatheter Aortic Valve Replacement in Bicuspid Aortic Stenosis.

Reference: Jing-Jing He, et al. J Am Coll Cardiol Intv 2022;15:1652–1660.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TEER plus optimal medical therapy versus medical therapy alone in functional mitral regurgitation

Mitral regurgitation (MR) is a highly prevalent valvular heart disease that, in advanced stages and when left untreated, is associated with reduced quality of...

VECTOR: First Percutaneous Aorto-Coronary Bypass Case, a New Conceptual Approach

Coronary obstruction represents one of the most severe complications associated with transcatheter aortic valve implantation, particularly in valve-in-valve scenarios involving surgical bioprostheses, narrow aortic...

Is it safe to use negative chronotropic drugs early after TAVI?

TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

TEER plus optimal medical therapy versus medical therapy alone in functional mitral regurgitation

Mitral regurgitation (MR) is a highly prevalent valvular heart disease that, in advanced stages and when left untreated, is associated with reduced quality of...

Hybrid Coronary Revascularization versus Conventional Bypass Surgery in Left Main Coronary Artery Disease

Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with complex multivessel disease and high SYNTAX scores,...